Given the role of exogenous GD3 in chemotherapy susceptibility [16] and its ability to disable survival pathways dependent on NF-κB activation [11], [12], the purpose of the present study was to examine the role of GD3 in hypoxia susceptibility and in vivo tumor growth. Here, NFKB1 is linked to neoplasm.